CNS Flashcards
Mechanism of action of antidepressant drugs
a. bupropion — inhibits reuptake of dopamine
a. True, bupropion inhibits the reuptake of dopamine and NE
Mechanism of action of antidepressant drugs
b. escitalopram — inhibits monoamine oxidase
b. False, escitalopram is an SSRI an inhibits the reuptake of serotonin
Mechanism of action of antidepressant drugs
c. moclobemide — inhibits chloride ion conductance
c. False, Moclobemide is a MAOI-A and thus decrease metabolism of dopamine
Mechanism of action of antidepressant drugs
d. imipramine — inhibits reuptake of noradrenaline
d. True, TCA antidepressant inhibit the reuptake of NE and serotonin
Mechanism of action of antidepressant drugs
e. venlafaxine — inhibits reuptake of serotonin
e. True, venlafaxine is an SNRI and thus inhibits the reuptake of serotonin and NE
Drugs for Parkinson’s Disease:
a. pramipexole is converted to dopamine in the neuron
a. False, pramipexole is a non-ergot derived dopamine receptor agonist that is taken orally.
Drugs for Parkinson’s Disease:
b. carbidopa prevents the peripheral conversion of levodopa to dopamine
b. True, carbidopa is a dopamine decarboxylase inhibitor and thus inhibits peripheral dopamine metabolism
Drugs for Parkinson’s Disease:
c. pramipexole increases the risk of sudden-onset sleep attacks
c. True, DRA cause sedation, hallucination, confusion and hypotension
Drugs for Parkinson’s Disease
d. selegiline inhibits monoamine oxidase B
d. True, selegiline is a MAOI-B
Drugs for Parkinson’s Disease:
e. levodopa is used in the treatment of nausea and vomiting :
e. False, levodopa causes nausea and vomiting
CNS drugs which increase the risk of insomnia include:
a. moclobemide
a. True, MAOI causes insomnia and hypertensive crisis
CNS drugs which increase the risk of insomnia include:
b. phenobarbitone
b. False, phenobarbitone is a barbiturate that is used as an anticonvulsant, sedative and hypnotic
CNS drugs which increase the risk of insomnia include:
c. olanzapine
c. False, antipsychotic with anti-histamine effects cause sedation
CNS drugs which increase the risk of insomnia include:
d. fluoxetine
d. True, SSRIs cause insomnia, nausea and vomiting, sexual dysfunction, weight gain
CNS drugs which increase the risk of insomnia include:
e. venlafaxine
e. True, SNRIs cause insomnia, hypertension, palpitations, tachycardia and SIADH
Drugs which enhance the effects of GABA include:
a. valproic acid
a. True, valproic acid is an anticonvulsant that inhibits gaba transaminase and thus, inhibits gaba metabolism
Drugs which enhance the effects of GABA include:
b. ethosuximide
b. False, ethosuximide is a calcium channel blocker used as an anticonvulsant
Drugs which enhance the effects of GABA include:
c. diazepam
c. True, BDZ enhance the effects of gaba
Drugs which enhance the effects of GABA include:
d. phenobarbitone
d. True, barbiturates enhance the effects of GABA
Drugs which enhance the effects of GABA include:
e. carbamazepine
e. False, carbamazepine is a calcium channel blocker used as an anticonvulsant
CNS drugs which cause weight gain include:
a. valproic acid
a. False, valproic acid causes hepatoxicity and is teratogenic
CNS drugs which cause weight gain include:
b. amitriptyline
b. True, TCA cause weight gain
CNS drugs which cause weight gain include:
c. gabapentin
c. True
.
CNS drugs which cause weight gain include:
d. olanzapine
d. True, antipsychotic causes weight gain
CNS drugs which cause weight gain include:
e. topiramate
e. False, topiramate is an anticonvulsant that causes weight loss
In the management of epilepsy
a. topiramate is a cognitive enhancing drug
a. False, topiramate causes cognitive disorder
In the management of epilepsy
b. maternal use of valproic acid in the first trimester of pregnancy increases the risk of fetal neural tube defects
b. True, valproic acid is teratogenic
In the management of epilepsy
c. when valproic acid is used as “add-on” therapy, the dose of lamotrigine is doubled
c. False, valproic acid decreases the excretion of lamotrigine. Thus, the dose could be lessened not increased
In the management of epilepsy
d. the metabolism of phenytoin is saturable
d. True, phenytoin and fosphenytoin exhibit saturable metabolism (zero-order kinetics)
In the management of epilepsy
e. phenobarbitone is a hepatic enzyme inhibitor
e. False, barbiturates act on GABA receptors
Antidepressant agents which BLOCK the reuptake of serotonin include:
a. fluoxetine
a. True, SSRIs block the reuptake of serotonin
Antidepressant agents which BLOCK the reuptake of serotonin include:
b. moclobemide
b. False, MAOI inhibit the metabolism of dopamine
Antidepressant agents which BLOCK the reuptake of serotonin include:
c. amitriptyline
c. True, TCA block the reuptake of serotonin and NE
Antidepressant agents which BLOCK the reuptake of serotonin include:
d. venlafaxine
d. True, SNRI block the reuptake of serotonin and NE
Antidepressant agents which BLOCK the reuptake of serotonin include:
e. bupropion
e. False, bupropion blocks the reuptake of NE and dopamine
Use of antidepressants INCREASES the risk of the listed side effects:
a. escitalopram — diarrhoea
a. True, SSRIs cause both diarrhoea and constipation
Use of antidepressants INCREASES the risk of the listed side effects:
b. fluoxetine — constipation
b. True, SSRIs cause both diarrhoea and constipation
Use of antidepressants INCREASES the risk of the listed side effects:
c. bupropion — sedation
c. False, bupropion will cause insomnia
Use of antidepressants INCREASES the risk of the listed side effects:
d. imipramine — seizures
d. True, in TCA overdose seizures can occur
Use of antidepressants INCREASES the risk of the listed side effects:
e. moclobemide — agitation
e. True, MAOI cause agitation
In the management of anxiety and insomnia
a. venlafaxine blocks reuptake of GABA
a. False, venlafaxine is an SNRI and thus blocks the reuptake of serotonin and NE
In the management of anxiety and insomnia
b. diazepam causes more daytime sedation than zolpidem
b. False ?
In the management of anxiety and insomnia
c. moclobemide increases the risk of social phobia
c. False, indicated for the treatment of social phobia
In the management of anxiety and insomnia
d. oxazepam is preferred to diazepam in elderly patients
d. True ?
In the management of anxiety and insomnia
e. diazepam causes muscle spasm as an adverse effect
e. False, Diazepam has muscle relaxant properties
The following drugs cause postsynaptic hyperpolarization:
a. diazepam
a. True, BDZ cause hyperpolarization
The following drugs cause postsynaptic hyperpolarization:
c. fluoxetine
b. False, SSRI don’t cause hyperpolarization
The following drugs cause postsynaptic hyperpolarization:
d. moclobemide
c. False, MAOI don’t cause hyperpolarization
The following drugs cause postsynaptic hyperpolarization:
e. oxazepam
d. True, BDZ cause hyperpolarization
Dopamine-2 receptor ANTAGONISTS include:
a. bupropion
a. False, bupropion is a NE and dopamine reuptake inhibitor
Dopamine-2 receptor ANTAGONISTS include:
b. venlafaxine
b. False, Venlafaxine is a serotonin and NE reuptake inhibitor
Dopamine-2 receptor ANTAGONISTS include:
c. haloperidol
c. True, haloperidol is a first gen anti-psychotic and thus binds D2 receptors
Dopamine-2 receptor ANTAGONISTS include:
d. risperidone
d. True, risperidone is a D2 and serotonin receptor antagonist